What women want: Lallemand launches probiotics for female health

Lallemand is targeting women suffering from conditions like bacterial vaginosis, vulvovaginal candidiasis and urinary tract infections (UTI)

The absence of any EU-approved health claims for probiotics hasn’t deterred Lallemand Health Solutions from launching a suite of probiotics addressing women’s health issues.

The Canadian firm says it has screened its bank of probiotic strains and selected some mainly from the Lactobacilli and Bifidobacteria families, whose properties and modes of action are particularly relevant to support different aspects of women’s health.

“We have one of the largest portfolios of probiotic strains, and we want to offer distributors a wide area of potential applications. In the same way we developed an oral health range earlier this year, we have now developed a women’s health offer, based on scientific data and the documentation of our strains,” Bérengère Feuz, Lallemand group marketing manager, told NutraIngredients.

Three health areas are being targeted: Feminine health, everyday health and age-specific health.

Target areas

With its feminine health offering, Lallemand is focusing on the role of the vaginal microflora. It says common infections such as bacterial vaginosis, vulvovaginal candidiasis and urinary tract infections (UTI) are linked to unbalanced microflora.

“Specific Lactobacillus species from Lallemand Health Solutions’ portfolio can help prevent the recurrence of these infections. Contrary to antimicrobial treatments, probiotics have no side effects, don’t eliminate other beneficial bacteria and do not favour antibiotic resistance,” said the company in a statement.

‘Everyday health’ relates to those aspects of health that are impacted by hormone fluctuations during the menstrual cycle. Lallemand’s everyday health strains target gastrointestinal discomfort, lower immunity and mood disorder.

For the age-specific health range, Lallemand says it has selected probiotic strains that address the issues encountered by women of child-bearing age, pregnant or undergoing the menopause.

These strains can be formulated into formats such as oral or vaginal capsules, orodispersible sticks or sachets of soluble powders.

Sufficient science?

Whilst the strains are backed by clinical data, Feuz admitted the science supporting the role of probiotics in women’s health is at an earlier stage than probiotic gut health research.

“Concerning the science linking probiotics to women's health, I wouldn’t say it is as advanced as for gut health, but the modes of action of probiotics, in particular their capacity to balance local microflora and maintain a protective shield, can be transferred from one area to the other. What we need now is probably more clinical trials for specific issues,” she said.

Despite a growing catalogue of clinical data for probiotics, none of the health claim dossiers submitted by the probiotics industry have received a positive opinion from the EFSA (European Food Safety Authority).

This means that although Lallemand’s women’s health portfolio is being launched globally, in one of its key markets, products containing the strains will be unable to carry claims. Asked how companies would be able to communicate the benefits of the new probiotic solutions for women's health without direct claims, Feuz said marketing strategies within Europe would be, “decided case-by-case by our partners”.

“Formulations will be done case-by-case, and the marketing approach in each country will be designed by our customers, depending on the local market and regulatory environment."

Related News

On-pack probiotic claims possible with medical women's health products, says Danish supplier Bifodan

Is the future of women’s health probiotics medical?

Dr Gregor Reid: “Imagine forty year old ineffective therapies are all we offer. What an unbelievable disservice to women and girls."

Neglected female microbiota research a ‘disgrace’; congress lights issues

"Talking about these things there are always questions that start to come into your head as a woman like: ‘Is this normal?’" © iStock.com

Overcoming the taboo of vaginal health – the next frontier of probiotics

Perhaps indicative of the problem, many stock photos on the subject of 'success' feature men.  iStock photo.

There aren't enough women making decisions at supplement companies, and that hurts growth, advocates say

Chr. Hansen’s Urex awarded first South Korean. Photo credit Free Grunge Textures

Chr. Hansen wins landmark probiotics health claim in South Korea

“The in vitro experiments demonstrated that all the five Lactobacillus strains tested possessed inhibitory action against the Candida strains..."

Probiotics backed for vaginal health: Study

Dutch firm upgrades EU probiotic (medical devices) claim

Dutch firm upgrades EU probiotic (medical devices) claim

Researchers close in on the ‘black box’ of bacterial vaginosis

Researchers close in on the ‘black box’ of bacterial vaginosis

Merck and Alliospharma target women with prebiotic

Related Products

See more related products

Comments (1)

drs. Telly Hendon - 16 Oct 2014 | 11:17

No further research needed: it is elementary

Vaginal infections are related to boweldysbiosis. Ask any woman who already for years attempts to clear the problem with probitics etc. All we need is a stable easy to use oroduct: Llamand has it? Please make it available! EU citizens are being too long held back to deal with their health by the always-in-the-way EFSA. Politics and protectionism should no longer hold manufacturers back. Go Llamand the women of Europe need you.

16-Oct-2014 at 11:17 GMT

Submit a comment

Your comment has been saved

Post a comment

Please note that any information that you supply is protected by our Privacy and Cookie Policy. Access to all documents and request for further information are available to all users at no costs, In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information maybe shared with the owners of that document or information.